West Virginia Code § 55-7G-3

Definitions
Open in Lexace · Ask the AI about this section
For the purpose of this article:
(1) "AMA Guides to the Evaluation of Permanent Impairment" means the American Medical
Association's Guides to the Evaluation of Permanent Impairment in effect at the time of the
performance of any examination or test on the exposed person required under this article.
(2) "Asbestos" means chrysotile, amosite, crocidolite, tremolite asbestos, anthophyllite
asbestos, actinolite asbestos, asbestiform winchite, asbestiform richterite, asbestiform
amphibole minerals and any of these minerals that have been chuemically treated or altered,
including all minerals defined as asbestos in 29 C. F. R. §1910 at the time an asbestos action
is filed.
(3) "Asbestos action" means a claim for damages or othaer civil or equitable relief presented
in a civil action arising out of, based on or related to the health effects of exposure to
asbestos, including loss of consortium, wrongful delath, mental or emotional injury, risk or
fear of disease or other injury, costs of medicasl monitoring or surveillance and any other
derivative claim made by or on behalf of a person exposed to asbestos or a representative,
spouse, parent, child or other relative of thiat person. The term does not include a claim for
compensatory benefits pursuant to wgorkers' compensation law or for veterans' benefits.
(4) "Asbestosis" means bilateral diffuse interstitial fibrosis of the lungs caused by inhalation
of asbestos fibers.
(5) "Board-certified in internal medicine" means a physician who is certified by the American
Board of Internal Medicine or the American Osteopathic Board of Internal Medicine and
whose certification w as current at the time of the performance of any examination and
rendition of aVny report required by this article.
(6) "Board-certified in occupational medicine" means a physician who is certified in the
subspecialty of occupational medicine by the American Board of Preventive Medicine or the
American Osteopathic Board of Preventive Medicine and whose certification was current at
the time of the performance of any examination and rendition of any report required by this
article.
(7) "Board-certified in pathology" means a physician who holds primary certification in
anatomic pathology or clinical pathology from the American Board of Pathology or the
American Osteopathic Board of Pathology, whose certification was current at the time of the
performance of any examination and rendition of any report required by this act, and whose
professional practice is principally in the field of pathology and involves regular evaluation
of pathology materials obtained from surgical or postmortem specimens.
(8) "Board-certified in pulmonary medicine" means a physician who is certified in the
subspecialty of pulmonary medicine by the American Board of Internal Medicine or the
American Osteopathic Board of Internal Medicine and whose certification was current at the
time of the performance of any examination and rendition of any report required by this
article.
(9) "Certified B-reader" means an individual who has qualified as a National Institute for
Occupational Safety and Health (NIOSH) "final" or "B-reader" of x-rays under 42 C. F. R.
§37.51(b), whose certification was current at the time of any readings requiered under this
article, and whose B-reads comply with the NIOSH B-Reader's Code of Ethics, Issues in
Classification of Chest Radiographs and Classification of Chest Radiogrraphs in Contested
Proceedings.
(10) "Chest x-ray" means chest films taken in accordance with all applicable state and
federal regulatory standards and taken in the posterior-antetrior view.
(11) "DLCO" means diffusing capacity of the lung for caarbon monoxide, which is the
measurement of carbon monoxide transfer from inspired gas to pulmonary capillary blood.
(12) "Exposed person" means a person whose sexposure to asbestos or silica or to asbestos-
containing or silica-containing products is the basis for an asbestos or silica action.
(13) "FEV1" means forced expiratory volume in the first second, which is the maximal
volume of air expelled in one second during performance of simple spirometric tests.
(14) "FEV1/FVC" means the ratio between the actual values for FEV1 over FVC.
(15) "FVC" means forced vital capacity, which is the maximal volume of air expired with
maximum effort from a position of full inspiration.
(16) "ILO" system and "ILO scale" mean the radiological ratings and system for the
classification of chest x-rays of the International Labor Office provided in Guidelines for the
Use of ILO International Classification of Radiographs of Pneumoconioses in effect on the
day any x-rays of the exposed person were reviewed by a certified B-reader.
(17) "Nonmalignant condition" means any condition that can be caused by asbestos or silica
other than a diagnosed cancer.
(18) "Official statements of the American Thoracic Society" means lung function testing
standards set forth in statements from the American Thoracic Society including
standardizations of spirometry, standardizations of lung volume testing, standardizations of
diffusion capacity testing or single-breath determination of carbon monoxide uptake in the
lung and interpretive strategies for lung function tests, which are in effect on the day of the
pulmonary function testing of the exposed person.
(19) "Pathological evidence of asbestosis" means a statement by a board-certified pathologist
that more than one representative section of lung tissue uninvolved with any other disease
process demonstrates a pattern of peribronchiolar or parenchymal scarring in the presence
of characteristic asbestos bodies graded 1(B) or higher under the criteria published in
Asbestos-Associated Diseases, 106 Archive of Pathology and Laboratory Medicine 11,
Appendix 3 (October 8, 1982), or grade one or higher in Pathology of Asbestosis, 134
Archive of Pathology and Laboratory Medicine 462-80 (March 2010) (Tables 2 and 3), or as
amended at the time of the exam, and there is no other more likely explanation for the
presence of the fibrosis.
(20) "Pathological evidence of silicosis" means a statement by a board-certified pathologist
that more than one representative section of lung tissue uninvolved witrh any other disease
process demonstrates complicated silicosis with characteristic confluent silicotic nodules or
lesions equal to or greater than one centimeter and birefringent crystals or other
demonstration of crystal structures consistent with silica (well-organized concentric whorls
of collagen surrounded by inflammatory cells) in the lung patrenchyma and no other more
likely explanation for the presence of the fibrosis exists, or acute silicosis with characteristic
pulmonary edema, interstitial inflammation, and the accumulation within the alveoli of
proteinaceous fluid rich in surfactant.
(21) "Plaintiff" means a person asserting an assbestos or silica action, a decedent if the action
is brought through or on behalf of an estate, and a parent or guardian if the action is
brought through or on behalf of a minor or incompetent.
(22) "Plethysmography or body (BOX) plethysmography" means the test for determining lung
volume in which the exposed peerson is enclosed in a chamber equipped to measure pressure,
flow or volume change.
(23) "Predicted lower limit of normal" means any test value is the calculated standard
convention lying at the fifth percentile, below the upper ninety-five percent of the reference
population, based on age, height and gender, according to the recommendations by the
American Thoracic Society and as referenced in the applicable AMA Guides to the
Evaluation of Permanent Impairment, primarily National Health and Nutrition Examination
SurWvey (NHANES) predicted values, or as amended.
(24) "Pulmonary function test" means spirometry, lung volume testing and diffusion capacity
testing, including appropriate measurements, quality control data and graphs, performed in
accordance with the methods of calibration and techniques provided in the applicable AMA
Guides to the Evaluation of Permanent Impairment and all standards provided in the Official
Statements of the American Thoracic Society in effect on the day pulmonary function testing
of the exposed person was conducted.
(25) "Qualified physician" means a board-certified internist, pathologist, pulmonary
specialist or specialist in occupational and environmental medicine, as may be appropriate to
the actual diagnostic specialty in question, that meets all of the following requirements:
(A) The physician has conducted a physical examination of the exposed person and has taken
or has directed to be taken under his or her supervision, direction and control, a detailed
occupational, exposure, medical, smoking and social history from the exposed person, or the
physician has reviewed the pathology material and has taken or has directed to be taken
under his or her supervision, direction and control, a detailed history from the person most
knowledgeable about the information forming the basis of the asbestos or silica action;
(B) The physician has treated or is treating the exposed person, and has or had a doctor-
patient relationship with the exposed person at the time of the physical exameination or, in
the case of a board-certified pathologist, examined tissue samples or pathological slides of
the exposed person; r
(C) The physician prepared or directly supervised the preparatioun and final review of any
medical report under this article; and
(D) The physician has not relied on any examinations, tests, radiographs, reports or opinions
of any doctor, clinic, laboratory or testing company thaat performed an examination, test,
radiograph or screening of the exposed person in violation of any law, regulation, licensing
requirement or medical code of practice of the statle in which the examination, test or
screening. s
(26) "Radiological evidence of asbestosis" imeans a quality 1 or 2 chest x-ray under the ILO
system, showing bilateral small, irreggular opacities (s, t or u) occurring primarily in the
lower lung zones graded by a certified B-reader as at least 1/0 on the ILO scale.
(27) "Radiological evidence of diffuse bilateral pleural thickening" means a quality 1 or 2
chest x-ray under the ILO system, showing diffuse bilateral pleural thickening of at least b2
on the ILO scale and blunting of at least one costophrenic angle as classified by a certified B-
reader.
(28) "RadiologVical evidence of silicosis" means a quality 1 or 2 chest x-ray under the ILO
system, showing bilateral predominantly nodular or rounded opacities (p, q or r) occurring in
the lung fields graded by a certified B-reader as at least 1/0 on the ILO scale or A, B or C
sized opacities representing complicated silicosis or acute silicosis with characteristic
pulmonary edema, interstitial inflammation, and the accumulation within the alveoli of
proteinaceous fluid rich in surfactant.
(29) "Silica" means a respirable crystalline form of silicon dioxide, including quartz,
cristobalite and tridymite.
(30) "Silica action" means a claim for damages or other civil or equitable relief presented in
a civil action arising out of, based on or related to the health effects of exposure to silica,
including loss of consortium, wrongful death, mental or emotional injury, risk or fear of
disease or other injury, costs of medical monitoring or surveillance and any other derivative
claim made by or on behalf of a person exposed to silica or a representative, spouse, parent,
child or other relative of that person. The term does not include a claim for compensatory
benefits pursuant to workers' compensation law, veterans' benefits or claims brought by a
person as a subrogee by virtue of the payment of benefits under a workers' compensation
law. The term does not include any administrative claim or civil action related to coal
workers' pnuemoconiosis.
(31) "Silicosis" means simple silicosis, acute silicosis, accelerated silicosis or chronic silicosis
caused by the inhalation of respirable silica. "Silicosis" does not mean coal workers'
pnuemoconiosis. e
(32) "Spirometry" means a test of air capacity of the lung through a spirometer to measure
the volume of air inspired and expired.
(33) "Supporting test results" means copies of the following documents and images:
(A) Pulmonary function tests, including printouts of the flow volume loops, volume time
curves, DLCO graphs, lung volume tests and graphs, qauality control data and other pertinent
data for all trials and all other elements required to demonstrate compliance with the
equipment, quality, interpretation and reporting stlandards set forth herein;
(B) B-reading and B-reader reports;
(C) Reports of x-ray examinations;
(D) Diagnostic imaging of the chest;
(E) Pathology reports; and
(F) All other tests reviewed by the diagnosing physician or a qualified physician in reaching
the physician's conclusions.
(34) "Timed gas dilution" means a method for measuring total lung capacity in which the
subject breathes into a spirometer containing a known concentration of an inert and
insoWluble gas for a specific time, and the concentration of that inert and insoluble gas in the
lung is compared to the concentration of that type of gas in the spirometer.
(35) "Total lung capacity" means the volume of gas contained in the lungs at the end of a
maximal inspiration.
(36) "Veterans' benefits" means a program for benefits in connection with military service
administered by the Veterans' Administration under Title 38 of the United States Code.
(37) "Workers' compensation law" means a law relating to a program administered by the
United States or a state to provide benefits, funded by a responsible employer or its
insurance carrier, for occupational diseases or injuries or for disability or death caused by
occupational diseases or injuries. The term includes the Longshore and Harbor Workers'
Compensation Act, 33 U. S. C. §§901 et seq., and the Federal Employees' Compensation Act,
Chapter 81 of Title 5 of the United States Code, but does not include the Federal Employers'
Liability Act of April 22, 1908, 45 U. S. C. §§51 et seq.

‹ Prev All West Virginia sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.